More than half the cancer patients require radiotherapy as part of cancer care
The World Health Organization (WHO) released technical specifications of procuring, using and maintaining radiotherapy devices commonly used in treatment of cancer. The publication, produced in collaboration with International Atomic Energy Agency (IAEA), draws from a 2008 IAEA paper on radiotherapy technical specifications.
More than 50 per cent cancer patients require radiotherapy as part of cancer care, the report mentioned. “IAEA data shows that around one-third of countries still do not have radiotherapy available, out of which 28 are in Africa,” said May Abdel-Wahab, Director of the IAEA’s Division of Human Health.
The guidance document covers major radiotherapy equipment, including those used in treatment, associated imaging, treatment planning software, information management and other ancillary devices.
The paper also specifies conditions for storing the devices like shielding for walls, floors and ceilings, among other things. It also describes how to maintain the equipment for them to have an optimal lifespan, which is usually 10-15 years.
Selecting radiotherapy systems appropriate for given settings and matched to the existing workforce help ensure the delivery of safe radiotherapy, said WHO in a press release on the publication.
Dr Bente Mikkelsen, director of the department of non-communicable diseases at WHO, said:
“While interruptions of radiotherapy equipment predate the novel coronavirus disease (COVID-19), they have been exacerbated during the pandemic because of breakdowns in global supply chains and barriers to the free movement of technical service personnel. Any improvement that reduces interruptions can make the difference between life and death for patients whose tumours continue growing while they await treatment.”
The document also reviewed recent and emerging technology and techniques in radiotherapy “that may have applicability in limited-resource settings in the future”.
The publication is intended for medical physicists, biomedical and clinical engineers, radiation oncologists, oncologists and anyone else with responsibility for manufacturing, planning, selecting, procuring, regulating, installing or using radiotherapy equipment.
We are a voice to you; you have been a support to us. Together we build journalism that is independent, credible and fearless. You can further help us by making a donation. This will mean a lot for our ability to bring you news, perspectives and analysis from the ground so that we can make change together.
Comments are moderated and will be published only after the site moderator’s approval. Please use a genuine email ID and provide your name. Selected comments may also be used in the ‘Letters’ section of the Down To Earth print edition.